首页> 外文期刊>Drug development and industrial pharmacy >Formulation development and human in vitro-in vivo correlation for a novel, monolithic controlled-release matrix system of high load and highly water-soluble drug niacin.
【24h】

Formulation development and human in vitro-in vivo correlation for a novel, monolithic controlled-release matrix system of high load and highly water-soluble drug niacin.

机译:高载量和高水溶性烟酸的新型整体式控释基质系统的配方开发和人体体外-体内相关性。

获取原文
获取原文并翻译 | 示例
           

摘要

Novel, controlled-release formulations for high drug load, highly water soluble compound niacin based on polyethylene oxide (PEO) and hydroxypropylmethyl cellulose (HPMC) matrices were developed and investigated. The effect of sodium bicarbonate as a modulator of swelling, erosion, and drug release and its impact on changes in the kinetics of axial swelling and gel strength were evaluated by textural analysis during dissolution study. The drug release rate from PEO-based matrices was faster and correlated with lower gel strength, greater water uptake, and greater matrix erosion. Slower release rate and greater release duration correlated significantly with greater matrix swelling with negligible matrix erosion for the HPMC-based matrix system. Inclusion of sodium bicarbonate in the polymeric matrix salted out the macromolecules and increased gel strength and gel viscosity, especially in the vicinity of the swelling fronts. An in vivo study in human subjects after administration of the formulations and a commercial product exhibited similar plasma concentrations. For the formulation of interest, the mean drug fraction absorbed by the body was calculated by the Wagner-Nelson technique, and a level A "in vitro-in vivo correlation" was observed between the percent released in vitro and percent absorbed in vivo. The developed formulations appear to be robust and easy to manufacture with maximum flexibility with respect to drug dose, polymeric carriers, duration, and kinetics of drug release.
机译:开发并研究了基于聚环氧乙烷(PEO)和羟丙基甲基纤维素(HPMC)基质的高载药量,高水溶性化合物烟酸的新型控释制剂。碳酸氢钠作为溶胀,腐蚀和药物释放调节剂的作用及其对轴向溶胀动力学变化和凝胶强度的影响通过溶出度研究中的组织分析进行了评估。从基于PEO的基质中释放药物的速度更快,并且与更低的凝胶强度,更大的吸水率和更大的基质侵蚀相关。对于基于HPMC的基质系统,较慢的释放速率和更长的释放持续时间与更大的基质溶胀和可忽略的基质侵蚀显着相关。聚合物基质中包含碳酸氢钠会使大分子盐析出来,并增加凝胶强度和凝胶粘度,特别是在溶胀前沿附近。施用制剂和市售产品后在人受试者中的体内研究显示相似的血浆浓度。对于感兴趣的制剂,通过Wagner-Nelson技术计算了身体吸收的平均药物分数,并且在体外释放的百分数和体内吸收的百分数之间观察到了A级“体外-体内相关性”。相对于药物剂量,聚合物载体,持续时间和药物释放动力学,开发的制剂似乎是坚固且易于制造的,具有最大的灵活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号